Swiss cirrhosis study for liver patients and controls
Part of Digestive system clinical trials.
This study compares patients with advanced liver scarring (cirrhosis) to healthy controls to learn more about the condition. It may help researchers better understand and manage liver disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have long-term liver disease and confirmed cirrhosis (advanced liver scarring).
- Or you must be a healthy individual without any signs of cirrhosis.
- You must be 18 years or older.
- You must not have liver cancer (hepatocellular carcinoma or cholangiocellular carcinoma).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the bacteria naturally living in your gut (the microbiome) to better understand liver cirrhosis. It does not test a new drug or treatment, only collects information and samples.
This study looks at infections in people with cirrhosis caused by hepatitis B or C. It aims to find which germs cause these infections, so doctors can choose better treatments.
This study looks at people over 18 who have advanced, long-term liver scarring. It uses specialized measurements of liver stiffness and pressure to confirm eligibility and may help doctors better understand this condition.
This study looks at the nutrition and dietary needs of people with cirrhosis (a type of long-term liver damage). It aims to understand how nutrition affects their health, so doctors can give better advice.
This study looks at how liver cirrhosis shows up on non-invasive imaging like CT scans, and how those findings relate to outcomes. It may help researchers better understand what scan patterns could signal disease severity.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.